All In Biotech

Drug Trial Radar · NCT03415997

Dosing Iodinated Contrast Media According to Lean vs. Total Body Weight

Dosing Iodinated Contrast Media According to Lean vs. Total Body Weight at Abdominal CT: a North American Randomized Controlled Trial

Last checked: Nov 20, 2026Latest source record: Jan 31, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 239 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

239

Actual

Start

Feb 21, 2018

Primary completion

Nov 9, 2018

Study completion Nov 9, 2018

Sponsor

Lead sponsor
Nova Scotia Health AuthorityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jan 30, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Diagnostic
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the effect of dosing iodinated contrast media according to a patient's total body weight vs. lean body weight. Participants will be randomized into 2 groups based on contrast dosing technique, and solid organ enhancement at uniphasic abdominal CT will be measured.

Conditions

  • Contrast Media Dosing

Interventions

  • IohexolDrug

    Iodinated contrast media

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean hepatic enhancement (MHE): difference in liver attenuation on computed tomography images acquired before and after administration of contrast (in portal venous phase), as measured in Hounsfield units (HU)Time frame: 1 hour

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Queen Elizabeth II Health Sciences Centre

    Halifax, Nova Scotia, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.